Delcath Systems Inc (DCTH)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Jennifer K. Simpson
Employees:
43
1633 BROADWAY, SUITE 22C, NEW YORK, NY 10019
(212) 489-2100

Delcath Systems, Inc. is a pharmaceutical and medical device company, which focuses on oncology and liver cancer therapy. It develops and commercializes Melphalan Hydrochloride for Injection, which is a proprietary product for use with the Delcath Hepatic Delivery System. It is designed to administer concentrated regional chemotherapy to the liver. The company was founded on August 5, 1988 and is headquartered in New York, NY.

Data derived from most recent annual or quarterly report
Market Cap 33.177 Million Shares Outstanding7.356 Million Avg 30-day Volume 31.881 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.96
Price to Revenue14.2745 Debt to Equity3.0293 EBITDA-24.396 Million
Price to Book Value9.6848 Operating Margin-715.0070999999999 Enterprise Value45.94 Million
Current Ratio2.931 EPS Growth0.081 Quick Ratio1.907
1 Yr BETA 0.6925 52-week High/Low 13.5 / 4.3 Profit Margin-1488.1241
Operating Cash Flow Growth-9.9343 Altman Z-Score-22.8149 Free Cash Flow to Firm -22.949 Million
Earnings Report2022-08-09
View SEC Filings from DCTH instead.

View recent insider trading info

Funds Holding DCTH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DCTH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

44.5 Thousand total shares from 22 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PURPURA JOHN CHIEF OPERATING OFFICER

  • Officer
27,021 2022-05-16 4

SALAMON STEVEN A J

  • Director
440,100 2022-05-13 15

STOLL ROGER G PHD

  • Director
9,000 2022-05-04 2

CZEREPAK ELIZABETH

  • Director
9,000 2022-05-04 2

DIAS ANTHONY VICE PRESIDENT OF FINANCE

  • Officer
0 2022-05-04 1

SYLVESTER JOHN RICHARD

  • Director
9,000 2022-05-04 2

AHARON GIL

  • Director
9,000 2022-05-04 5

MUIR KEVIN SEE REMARKS

  • Officer
0 2022-05-04 1

HOFFMAN DAVID L. SEE REMARKS

  • Officer
0 2022-05-04 1

ROSALIND ADVISORS, INC.

  • Director
433,100 2022-04-19 11

MICHEL GERARD J SEE REMARKS

  • Officer
  • Director
63,050 2022-04-18 6

JOHN JOHNNY SEE REMARKS

  • Officer
0 2022-04-04 1

PADULA CHRISTINE SEE REMARKS

  • Officer
30,000 2021-09-01 1

RUECKERT WILLIAM DODGE

  • Director
6,014 2020-05-08 0

TAGLIETTI MARCO

  • Director
6,001 2020-05-08 0

KECK BARBRA SEE REMARKS

  • Officer
12,851 2020-05-06 0

SIMPSON JENNIFER K. PRESIDENT AND CEO

  • Officer
  • Director
25,021 2020-05-06 0

PEDDER SIMON

  • Director
0 2019-02-01 0

PHILIPS LAURA A

  • Director
205,299 2015-07-22 0

LANGER DENNIS

  • Director
20,000 2015-06-10 0

KOPLEWICZ HAROLD S

  • Director
45,052 2015-06-10 0

WATSON DOUGLAS G

  • Director
7,938 2014-07-10 0

LEUNG GABRIEL

  • Director
21,485 2014-07-07 0

KONIDARIS TASOS

  • Director
11,678 2014-07-07 0

BREGE LAURA

  • Director
11,678 2014-07-07 0

GRAHAM PETER J EVP; GENERAL COUNSEL

  • Officer
0 2013-11-14 0

MIAO GRAHAM G INTERIM CO-CEO & PRES.EVP, CFO

  • Officer
0 2013-11-14 0

APPLING WILLIAM M EVP, R&D AND GLOBAL OPERATIONS

  • Officer
0 2013-07-15 0

GAGO AGUSTIN V EVP GLOBAL SALES & MARKETING

  • Officer
0 2013-03-11 0

HOBBS EAMONN P PRESIDENT AND CEO

  • Officer
  • Director
0 2013-03-11 0

MAPES HAROLD EXEC. V. P., GLOBAL OPERATIONS

  • Officer
0 2013-03-11 0

KANDARPA KRISHNA EXEC. V.P., CHIEF MEDICAL OFF.

  • Officer
0 2013-03-11 0

LADD ROBERT

  • Director
700,828 2012-06-15 0

MCDONALD DAVID CHIEF FINANCIAL OFFICER

  • Officer
47,706 2011-03-10 0

CONTAG PAMELA REILLY

  • Director
8,507 2010-12-01 0

TANEY RICHARD

  • Director
211,485 2009-12-10 0

RIFKIN JASON ANDREW SR. VP CLINICAL OPER. & SECY

  • Officer
0 2009-10-12 0

LEWIS JONATHAN

  • Director
10,000 2008-06-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PURPURA JOHN - Officer CHIEF OPERATING OFFICER

2022-05-18 10:42:29 -0400 2022-05-16 P 3,300 $4.61 a 27,021 direct -1.1111 0.0 1 -1.1111 2

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-05-16 12:04:39 -0400 2022-05-13 P 5,000 $5.03 a 440,100 indirect -4.9041 0.0 1 -4.9041 2

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-05-13 12:12:16 -0400 2022-05-12 P 6,000 $4.90 a 29,424 indirect -2.8986 -6.6253 0.0 1 -7.8675 5

SYLVESTER JOHN RICHARD - Director

2022-05-06 13:42:02 -0400 2022-05-04 A 9,000 a 9,000 direct

AHARON GIL - Director

2022-05-06 14:45:44 -0400 2022-05-04 A 9,000 a 9,000 direct

STOLL ROGER G PHD - Director

2022-05-06 13:50:41 -0400 2022-05-04 A 9,000 a 9,000 direct

CZEREPAK ELIZABETH - Director

2022-05-06 13:45:42 -0400 2022-05-04 A 9,000 a 9,000 direct

SALAMON STEVEN A J - Director

2022-05-06 14:53:24 -0400 2022-05-04 A 9,000 a 9,000 direct

ROSALIND ADVISORS, INC. - Director by rosalind advisors, inc., the advisor to the rosalind funds

2022-04-21 12:42:44 -0400 2022-04-19 P 1,600 $6.25 a 433,100 indirect -0.3155 -5.0473 0.1577 3 -5.0473 6

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-04-20 15:47:02 -0400 2022-04-19 P 1,600 $6.25 a 429,100 indirect -0.3155 -5.0473 0.1577 3 -5.0473 6

MICHEL GERARD J - Director - Officer SEE REMARKS

2022-04-18 21:23:59 -0400 2022-04-18 P 200 $6.34 a 61,250 direct -0.4702 -1.2539 0.0 1 -1.2539 6

ROSALIND ADVISORS, INC. - Director by rosalind advisors, inc., the advisor to the rosalind funds

2022-04-19 13:52:49 -0400 2022-04-18 P 2,000 $6.35 a 431,500 indirect -0.4702 -1.2539 0.0 1 -1.2539 6

AHARON GIL - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-04-19 13:52:01 -0400 2022-04-18 P 2,000 $6.35 a 404,000 indirect -0.4702 -1.2539 0.0 1 -1.2539 6

MICHEL GERARD J - Director - Officer SEE REMARKS

2022-04-18 21:23:59 -0400 2022-04-18 P 1,800 $6.37 a 63,050 direct -0.4702 -1.2539 0.0 1 -1.2539 6

ROSALIND ADVISORS, INC. - Director by rosalind advisors, inc., the advisor to the rosalind funds

2022-04-14 17:20:40 -0400 2022-04-13 P 1,500 $6.45 a 429,500 indirect 1.5924 1.1146 1.5924 2 0.0 1

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-04-14 13:47:46 -0400 2022-04-13 P 1,500 $6.45 a 427,500 indirect -2.0281 -1.4041 0.0 1 -2.0281 2

ROSALIND ADVISORS, INC. - Director by rosalind advisors, inc., the advisor to the rosalind funds

2022-04-12 18:42:33 -0400 2022-04-12 P 2,500 $6.48 a 428,000 indirect 0.1563 -0.9375 0.1563 2 -1.875 3

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-04-12 17:58:52 -0400 2022-04-12 P 2,500 $6.48 a 425,000 indirect 0.1563 -0.9375 0.1563 2 -1.875 3

PURPURA JOHN - Officer CHIEF OPERATING OFFICER

2022-04-11 16:11:02 -0400 2022-04-11 P 5,000 $6.59 a 23,721 direct -0.9288 -1.7028 0.0 1 -2.7864 4

MICHEL GERARD J - Director - Officer SEE REMARKS

2022-04-08 18:25:32 -0400 2022-04-08 P 1,000 $6.59 a 60,050 direct 0.78 -0.468 0.78 2 -2.0281 5

MICHEL GERARD J - Director - Officer SEE REMARKS

2022-04-08 18:25:32 -0400 2022-04-08 P 1,000 $6.55 a 61,050 direct 0.78 -0.468 0.78 2 -2.0281 5

ROSALIND ADVISORS, INC. - Director by rosalind advisors, inc., the advisor to the rosalind funds

2022-04-08 09:43:54 -0400 2022-04-07 P 1,000 $6.41 a 425,500 indirect 0.1563 -1.875 0.9375 3 -1.875 6

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-04-08 11:23:17 -0400 2022-04-07 P 1,000 $6.41 a 423,500 indirect 0.1563 -1.875 0.9375 3 -1.875 6

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-04-08 09:44:44 -0400 2022-04-07 P 1,000 $6.41 a 423,500 indirect 0.1563 -1.875 0.9375 3 -1.875 6

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-04-08 09:44:44 -0400 2022-04-06 P 1,000 $6.49 a 422,500 indirect 0.1563 -1.875 0.9375 3 -1.875 6

ROSALIND ADVISORS, INC. - Director by rosalind advisors, inc., the advisor to the rosalind funds

2022-04-08 09:43:54 -0400 2022-04-06 P 1,000 $6.49 a 424,500 indirect 0.1563 -1.875 0.9375 3 -1.875 6

SALAMON STEVEN A J - Director by individual as officer of rosalind advisors, inc., the advisor to the rosalind funds

2022-04-08 11:23:17 -0400 2022-04-06 P 1,000 $6.49 a 422,500 indirect 0.1563 -1.875 0.9375 3 -1.875 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
DELCATH SYSTEMS INC DCTH 2022-05-20 22:15:03 UTC -9.2011 10.0211 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 21:45:03 UTC -9.0745 9.8945 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 21:15:03 UTC -9.0745 9.8945 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 20:45:03 UTC -8.8083 9.6283 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 20:15:05 UTC -8.8083 9.6283 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 19:45:03 UTC -8.8083 9.6283 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 19:15:04 UTC -8.8083 9.6283 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 18:45:03 UTC -8.5418 9.3618 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 18:15:03 UTC -8.5418 9.3618 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 17:45:03 UTC -8.5418 9.3618 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 17:15:03 UTC -8.5418 9.3618 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 16:45:04 UTC -8.5418 9.3618 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 16:15:03 UTC -8.5418 9.3618 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 15:45:03 UTC -8.5418 9.3618 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 15:15:03 UTC -8.5418 9.3618 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 14:45:03 UTC -8.0482 8.8682 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 14:15:04 UTC -8.0482 8.8682 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 13:45:03 UTC -8.0482 8.8682 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 13:15:03 UTC -8.0482 8.8682 150000
DELCATH SYSTEMS INC DCTH 2022-05-20 12:45:03 UTC -8.0482 8.8682 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments